• Read more about Cellworks Biosimulation Combined with Tumor Microenvironment Modeling Enhances Predictions of IO Response in NSCLC Patients

Study finds utilizing genomic and transcriptomic data with biosimulation enhances personalized predictions of IO response in NSCLC

• Read more about Cellworks Biosimulation Predicts PARPi Benefit in Patients with Ovarian, Pancreatic, Prostate and Triple-Negative Breast Cancers

Personalized Therapy Biosimulation Study Identifies Homologous Recombination Deficiency in Cancer Patients Beyond BRCA Status

• Read more about Cellworks Biosimulation Identifies which NSCLC Patients will Benefit from Combining Chemotherapy with Immunotherapy

• Read more about Cellworks Biosimulation Identifies which NSCLC Patients will Benefit from Combining Chemotherapy with Immunotherapy

New study validates Cellworks predictions of chemotherapy benefits in real-world NSCLC patients, guiding treatment decisions beyond PD-L1 status

• Read more about Cellworks Biosimulation Predicts Chemotherapy Benefit in Osimertinib-treated NSCLC Patients with EGFR Mutations

Study Uncovers Biomarkers Linked to Chemotherapy Response in NSCLC Patients Carrying EGFR Variants

• Read more about Cellworks Aims to Validate Clinical Decision Support Capabilities of Computational Model

• Read more about Dr. Michael Donovan Joins Cellworks to Oversee Personalized Cancer Therapy Biosimulation in New CLIA-Certified Lab

Cellworks Opens a Computational Laboratory to Advance Personalized Therapy Decision Support

• Read more about Predicting Everolimus Response in Rare Metastatic Thymic Epithelial Tumors
• Add new comment

Thymic tumors, while rare, are classified as orphan diseases due to their infrequency. Despite their rarity, they are the predominant tumors found in the anterior mediastinal compartment among adults.

Thymic tumors represent a wide variety of tumors and the most recent histologic classification classifies them as thymomas, thymic carcinomas (TC), and neuroendocrine thymic tumors (NETT). Although thymic tumors have traditionally been considered orphan diseases, in the last few decades there has been an increased interest in thymic malignancies in the scientific community.

• Read more about Cellworks Personalized Therapy Biosimulation Study Produces Superior OS and DFS Predictions for Gastroesophageal Cancer Patients

Peer-Reviewed Research Indicates Whole Genome Biosimulation Holds Promise for Personalized Therapy Selection in Clinical Settings

• Read more about Engineering-level molecular diagnosis: A necessity for cancer treatment—and for a successful Moonshot